Biorestorative Therapies (BRTX)
(Delayed Data from NSDQ)
$1.36 USD
-0.04 (-2.51%)
Updated Aug 9, 2024 04:00 PM ET
4-Sell of 5 4
F Value D Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Earnings Date | *AMC8/13/24 |
---|---|
Current Quarter | -0.56 |
EPS Last Quarter | -0.53 |
Last EPS Surprise | -3.92% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.16 |
Next Year | -1.84 |
EPS (TTM) | -2.51 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.03M | 0.03M | 0.13M | 0.12M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 0.03M | 0.03M | 0.13M | 0.12M |
Low Estimate | 0.03M | 0.03M | 0.13M | 0.12M |
Year ago Sales | 0.07M | 0.03M | 0.15M | 0.13M |
Year over Year Growth Est. | -57.14% | 0.00% | -10.95% | -7.69% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.56 | -0.63 | -2.16 | -1.84 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -0.56 | -0.63 | NA | -1.84 |
High Estimate | -0.56 | -0.63 | -2.16 | -1.84 |
Low Estimate | -0.56 | -0.63 | -2.16 | -1.84 |
Year ago EPS | -0.77 | -0.64 | -3.42 | -2.16 |
Year over Year Growth Est. | 27.27% | 1.56% | 36.84% | 14.81% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.56 | -0.63 | -2.16 | -1.84 |
7 Days Ago | -0.56 | -0.63 | -2.16 | -1.84 |
30 Days Ago | -0.56 | -0.63 | -2.16 | -1.84 |
60 Days Ago | -0.46 | -0.52 | -1.96 | -1.52 |
90 Days Ago | -0.46 | -0.52 | -1.96 | -1.52 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.56 | -0.63 | -2.16 | -1.84 |
Zacks Consensus Estimate | -0.56 | -0.63 | -2.16 | -1.84 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.53 | -0.57 | -0.64 | -0.77 | NA |
Estimate | -0.51 | -0.65 | -0.68 | -1.56 | NA |
Difference | -0.02 | 0.08 | 0.04 | 0.79 | 0.22 |
Surprise | -3.92% | 12.31% | 5.88% | 50.64% | 16.23% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more